ARIEL4 (Assessment of Rucaparib In Ovarian CancEr TriaL): A Phase 3 Multicentre, Randomized Study of Rucaparib Versus Chemotherapy in Patients With Relapsed, BRCA Mutant, High Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
The purpose of this study is to determine how patients with ovarian, fallopian tube, and
primary peritoneal cancer will best respond to treatment with rucaparib versus chemotherapy.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society